Drug
BEBT-209 clinical trials
Also written KCBI-0191.
Keep track of what changes. Save the BEBT-209 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
BeBetter Med Inc (3)
Studies
Open first, then newest update. How each study uses BEBT-209 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast CancerRecruitingPhase 2/3BeBetter Med IncNCT07544056Written as BEBT-209 capsules
- Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine TherapyRecruitingPhase 3BeBetter Med IncNCT06998108Written as BEBT-209 capsules
- A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast CancerCompletedPhase 2BeBetter Med IncNCT06685796Written as BEBT-209 capsules